Skip to content
RushPR News – Lifestyle
Author:
BriaCell Therapeutics Corp.
BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer
July 16, 2026
BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™
July 15, 2026
BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™
July 7, 2026
BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™
June 25, 2026
BriaCell Therapeutics Announces Closing of Offering
June 2, 2026
BriaCell Presents Positive Clinical Data at ASCO 2026
June 1, 2026
BriaCell Therapeutics Announces Pricing of Offering
May 31, 2026
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
May 26, 2026
BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026
May 22, 2026
BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™
May 15, 2026
1
2
Next Page
→